Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

130 results about "Free medium" patented technology

Modified vaccinia ankara virus variant and cultivation method

The present invention provides an attenuated virus, which is derived from Modified Vaccinia Ankara virus and characterized by the loss of its capability to reproductively replicate in human cell lines. It further describes recombinant viruses derived from this virus and the use of the virus, or its recombinants, as a medicament or vaccine. A method is provided for inducing an immune response in individuals who may be immune-compromised, receiving antiviral therapy, or have a pre-existing immunity to the vaccine virus. In addition, a method is provided for the administration of a therapeutically effective amount of the virus, or its recombinants, in a vaccinia virus prime / vaccinia virus boost innoculation regimen. The present invention relates to a method of virus amplification in primary cells which are cultivated in a serum free medium. Viruses produced by this method are advantageously free of any infectious agents comprised in animal sera.
Owner:BAVARIAN NORDIC AS

Medium access control in wireless local area network

A medium access control method of a CSMA / CA (Carrier Sense Multiple Access with Collision Avoidance) based wireless LAN (Local Area Network) provides contention-free medium access authority to a station or access point receiving a request signal by: transmitting a request signal frame from an arbitrary station to another arbitrary station or to an access point via a medium occupied in transmission contention with a CSMA / CA algorithm using a DCF (Distributed Coordination Function) interframe space; and transmitting an acknowledgment signal frame from the station or the access point receiving the request signal frame to the station transmitting the request signal frame via an occupied medium using a short interframe space.
Owner:SAMSUNG ELECTRONICS CO LTD

Animal product free media and processes for obtaining a botulinum toxin

Media and processes for the fermentation of Clostridium botulinum and obtaining a botulinum toxin for use in formulating botulinum toxin pharmaceutical compositions. The growth media can contain significantly reduced levels of meat or dairy by-products using non-animal based products to replace the animal-derived products. Preferably, the media used are substantially free of animal derived products.
Owner:ALLERGAN INC

Zea mays (L.) with capability of long term, highly efficient plant regeneration including fertile transgenic maize plants having a heterologous gene, and their preparation

InactiveUS6284945B1Careful shakingPromote shakingTransferasesPlant tissue cultureHeterologousCallithamnion granulatum
Protoplasts which regenerate reproducibly in a short time to normal, fertile plants can be regenerated from an auxin-autotrophic genotype of Zea mays (L.). Starting from immature embryos on hormone-free media, an auxin-autotrophic, embryogenic callus is formed on the shoot basis of the seedlings, which callus retains its embryogenic potential over a substantial period of time when subcultured on hormone-free medium. In addition to fully-developed embryos, adventitious embryos are also formed under suitable culture conditions (6-9% of sucrose in the medium). When the sucrose content is reduced to 2-3% and 2,4-dichlorophenoxyacetic acid is added, soft, granular calli are formed which consist of embryogenic cell aggregates (type II callus). After subculturing the type II callus in the form of a cell suspension culture, totipotent protoplasts can be isolated. From these protoplasts, the maize plants according to the invention are regenerated.
Owner:BAYER CROPSCIENCE AG

Medium access method for contention and non-contention

In contention and contention-free medium access methods, a first set of stations is used for no-contention and a second set of stations is used for contention. The method comprises (a) preparing a contention-free access message attempting to access a first group; (b) detecting a transmission time of a contention-free access message attempting to access a second group; (c) embedding the contention-free access message into contention access message to transmit the embedded message to at least one of the first and second groups; and (d) receiving at least one of the first and second groups a contention-free access message embedded Access messages are contended for and priority is given to either of the first and second groups to access the medium in turn. Therefore, the multi-poll distribution coordination function (MP-DCF) mechanism based on the control of polling times is shared with the commercial sites without MP-DCF modules, in order to solve the shortcomings that all sites need to have MP-DCF modules, and despite the site's The number is gradually increased to be able to maintain the throughput stably.
Owner:SAMSUNG ELECTRONICS CO LTD

Warm-hot forming method for boron-free medium-manganese steel

InactiveCN104726762ALow austenitizing heating temperatureLow stamping temperatureShaping toolsManufacturing cost reductionFuel conservation
The invention discloses a warm-hot forming method for boron-free medium-manganese steel. The method is characterized by comprising the following steps: austenitizing pretreatment, namely heating a sheet to 750-820 DEG C at the heating rate of not lower than 10 DEG C/s, and carrying out heat preservation for 3-10 minutes; a sheet transferring process, namely cooling the sheet to a stamping temperature of 450-700 DEG C at the cooling rate of not lower than 5 DEG C/s, and transferring to a stamping mold; heat-resistant stamping and pressurizing-quenching treatment, namely transporting the sheet below the stamping mold, forming, and simultaneously carrying out heat-retaining quenching, wherein the quenching cooling rate is greater than 5 DEG/s; and the pressurizing time is 5-20s; and post-treatment, namely carrying out shot blasting on a formed sample piece, and anti-rust oil coating treatment. The warm-hot forming method provided by the invention conforms to industrial production of the boron-free medium-manganese steel, and has the advantages that the manufacture cost is reduced and the strength and plasticity of a steel part are improved; the new generation of automobile is promoted to reach a relatively high step in the aspects of light weight, fuel conservation and safety; and the warm-hot forming method is simple in technological process and convenient to operate.
Owner:DALIAN UNIV OF TECH

Separation and purification method of human umbilical cord mesenchymal stem cell exosome and application of human umbilical cord mesenchymal stem cell exosome

The invention provides a separation and purification method of a human umbilical cord mesenchymal stem cell exosome and an application of the human umbilical cord mesenchymal stem cell exosome, and belongs to the technical field of medicines. The human umbilical cord mesenchymal stem cell exosome provided by the invention is prepared by cultivating human umbilical cord mesenchymal stem cells via aserum-free medium, collecting supernatant liquid, implementing centrifuging as well as ultra-filtration and concentration, transferring a concentrated solution onto a 30% sucrose-heavy water densitypad and implementing further purification through sucrose density centrifuging, so that the human umbilical cord mesenchymal stem cell exosome is obtained. According to the separation and purificationmethod that the human umbilical cord mesenchymal stem cell exosome is obtained through separation and purification, immunoreactivity is effectively reduced, and a controllable dosage when the human umbilical cord mesenchymal stem cell exosome is used is guaranteed. The human umbilical cord mesenchymal stem cell exosome, by improving a degree of activating an insulin signaling pathway of a type IIdiabetes animal model, can inhibit composition and decomposition of hepatic glycogen, so that glucose metabolism homeostasis can be achieved; and meanwhile, the sensitivity of the type II diabetes animal model to insulin and an insulin secretion function of pancreatic [beta] cells can be improved and a blood glucose concentration can be reduced, so that the application of the human umbilical cordmesenchymal stem cell exosome to the preparation of medicines for treating type II diabetes can be achieved.
Owner:JIANGSU UNIV

A manufacturing process of annealing-free medium and high carbon steel plate

The invention relates to an annealing-free medium-high carbon steel plate making technology, and belongs to the technical field of steel rolling technologies. A technical scheme adopted in the invention is characterized in that the technology comprises the operations of heating furnace heating, vertical roll rolling, roughing scale removal, roughing rolling, intermediate cooling, precision rolling scale removal, precision rolling, laminar cooling, reeler reeling and concentrated pile cooling, the intermediate cooling operation is carried out after the roughing rolling operation and before the precision rolling scale removal operation and is realized through cooling plate blanks by a cooling device, and the cooling capability of the cooling device makes the temperature of the plate blanks decrease to below 840DEG C. The technology has the following beneficial effects: the elongation rate after fracture of produced products obviously rises, the hardness of the products decreases by 7.2-21%, the proportion of ferrite in the structure of the products is above 60%, ferrite crystal grains are appropriately coarsened, the pearlite colony is small and dispersed, and the cementite sheet in pearlite is attenuated, fragmented and partially granulated. An annealing operation after rolling can be avoided because of the low hardness and high plasticity in order to reach an online softening purpose.
Owner:HEBEI IRON AND STEEL

Immortal unipotent porcine PICM-19H and PICM-19B stem cell lines

InactiveUS20090291064A1Confirmed its differentiationLow levelBiocideHepatocytesLipid formationArtificial liver
Two cell lines, PICM-19H and PICM-19B, were derived from the bipotent ARS-PICM-19 pig liver stem cell line and assessed for their potential application in artificial liver devices. The study included assessments of growth rate and cell density in culture, morphological features, and hepatocyte detoxification functions, i.e., inducible CYP450 activity, ammonia clearance, and urea production. The PICM-19H cells contain numerous mitochondria, Golgi apparatus, smooth and rough endoplasmic reticulum, vesicular bodies and occasional lipid vacuoles. PICM-19H cells display inducible CYP450 activity, clear ammonia, and produce urea in a glutamine-free medium. Ultrastructural analysis of the PICM-19B monolayers show that the roughly cuboidal cells display basal-apical polarization and are joined by tight junction-like complexes. Other ultrastructure features are similar to those of PICM-19H cells except that they possess numerous cell bodies resembling mucus vacuoles. The PICM-19B cells possess relatively high levels of GGT activity, but retain some inducible CYP450 activity, and some ammonia clearance and urea synthesis ability. These data indicate that both cell lines, either together or alone, may be useful as the cellular substrate for an artificial liver device. In vitro models of the liver are needed to replace animal models for the rapid assessment of drug biotransformation and toxicity. A unipotent porcine stem cell line PICM-19H differentiates exclusively into hepatocytes and can be induced to express CYP450 enzymes. These cells have many activities associated with xenobiotic phase I and phase II metabolism lacking in other liver cell lines. The PICM-19H cell line was also compared to the tumor-derived human HepG2 C3A cell line and to primary cultures of adult porcine hepatocytes. The results demonstrate the potential for the use of PICM-19H cells in drug biotransformation and toxicity testing and further support their use in artificial liver device technology.
Owner:UNITED STATES OF AMERICA

High-medium single-layer miniature ceramic capacitor substrate material and preparation method thereof

The invention provides a high-medium single-layer miniature ceramic capacitor substrate material. Raw materials comprise main ingredients and doping agents. Chemical components of the main ingredients are SrTiO3. The doping agents are composed of, by mass, mwt% of Nb2O5, nwt% of SiO2, pwt% of Y2O3, qwt% of CaSnO3 and rwt% of composite oxide additives. The preparation method includes batching, ball-milling, drying, pelleting, forming, glue discharging, reduction atmosphere sintering and oxidation heat treatment. No Pb, Cd or other volatile or heavy metal elements are contained in the formula of the high-medium single-layer miniature ceramic capacitor substrate material, and the high-medium single-layer miniature ceramic capacitor substrate material is an environment-friendly and pollution-free medium ceramic material. The sintering temperature of ceramic is 1340-1400 DEG C, the dielectric constant is high, and a certain energy-saving advantage is achieved; the raw materials are sufficiently supplied at home, price is low, and the high-medium single-layer miniature ceramic capacitor substrate material is suitable for manufacturing high-performance communication components in the modern communication technology.
Owner:UNIV OF ELECTRONIC SCI & TECH OF CHINA

Serum-free medium used for culture of elderly people cartilage cells

The invention discloses a serum-free medium used for culture of elderly people cartilage cells, the-free medium comprises a basal medium and an additive comprising the components of the following concentration: 233muM-287 muM of vitamin C, 3.7mu M-8.9 muM of linoleic acid, 9muM-17 muM of cholesterol, 6nM-15 nM of dexamethasone, 43 muM-58mu M of acetyl cysteine, 18 mug / mL-32 mu g / mL of transferrin, 22nM-52 nM of sodium selenite, 13 muM-24 muM of sodium pantothenate, 28 muM-43 muM of biotin, 7 mug / mL-18 mu g / mL of insulin, 2 ng / mL-9 ng / mL of epidermal growth factor, 2 ng / mL-9 ng / mL of fiber growth factor, 2 ng / mL-9 ng / mL of platelet derived growth factor, and 0.5%-2.5% of human serum albumin. The cell culture time is short, and the cell biological performance is good.
Owner:HANGZHOU LONGHILL BIO MEDICATION TECH

Silver-based cadmium-free medium-temperature solder and preparation method thereof

The invention provides silver-based cadmium-free medium-temperature solder and a preparation method thereof and relates to medium-temperature solder and a preparation method thereof. The invention aims to solve the problems of high cost and high melting temperature of silver-based cadmium-free solder produced in the prior art. The silver-based cadmium-free medium-temperature solder is prepared from the following components in part by weight: 49 to 52 parts of silver, 14 to 16 parts of electrolytic copper, 2 to 3 parts of indium, 8 to 12 parts of stannum, 8 to 13 parts of zinc, 1.0 to 2.0 parts of copper phosphorus alloy, 1.0 to 1.5 parts of manganese, 0.2 to 0.7 part of zirconium and 5.05 to 10.8 parts of copper foil wrapped rare earth lanthanum. The preparation method particularly comprises the following steps of: 1, melting and mixing; 2, casting; and 3, extruding. The silver-based cadmium-free medium-temperature solder and the preparation method thereof have the advantages that: 1,the preparation cost is low and the prepared silver-based cadmium-free medium-temperature solder is low in temperature; 2, cadmium is not contained, so damage to a human body and environmental pollution are reduced; and 3, the plastic toughness is high, so a welding wire and a welding ring with the diameter of 0.5 to 2.0 can be prepared. The method is mainly used for preparing the silver-based cadmium-free medium-temperature solder.
Owner:HARBIN INST OF TECH

Method of preparing single-capric lauric glyceride through step-by-step catalysis of camphor tree seed oil with acid and base

The invention relates to a method of preparing single-capric lauric glyceride through step-by-step catalysis of camphor tree seed oil with acid and base, which comprises the following steps: degumming and dehydrating crude oil made from camphor tree seeds, adding the degummed and dehydrated oil into an esterification and alcoholysis reactor, adding an acid catalyst, and centrifugalizing when the acid value is reduced to be below 0.8 in reaction under the reaction conditions that the temperature is 130-140 DEG C, the amount of the consumed catalyst is 2-4 percent of the oil weight, the molar ratio of methanol to oil is 2:1 to 3:1; adding the reactants into an alcoholysis reactor, adding an alkali catalyst, and centrifugalizing when the total content of fatty acid monoglyceride reaches above 80.0 percent under the reaction conditions that the reaction temperature is 165-175 DEG C, the amount consumed catalyst is -.5-0.7 percent of the oil weight and the molar ratio of methanol to oil is 4:1 to 5:1; and spraying cold water at a temperature of 15-35 DEG C, mixing, washing, centrifugalizing, repeating the steps twice and finally dehydrating under a vacuum condition. The invention can effectively utilize the free medium-carbon-chain fatty acid in raw materials, and achieve high reaction efficiency. The fatty acid monoglyceride in the products can reach above 80.0 percent, and the content of the single-capric lauric glyceride can reach above 75.0 percent. Moreover, the invention has the advantages of reasonable process, energy conservation and environmental protection.
Owner:NANCHANG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products